Home/Filings/4/0001999371-24-002950
4//SEC Filing

MORRIS JESSICA EDGAR 4

Accession 0001999371-24-002950

CIK 0001430306other

Filed

Feb 28, 7:00 PM ET

Accepted

Feb 29, 5:06 PM ET

Size

8.0 KB

Accession

0001999371-24-002950

Insider Transaction Report

Form 4
Period: 2024-02-27
MORRIS JESSICA EDGAR
Chief Operating Officer
Transactions
  • Award

    Stock Option

    2024-02-27+317,000317,000 total
    Exercise: $0.37From: 2025-02-27Exp: 2034-02-27Common Stock (317,000 underlying)
  • Award

    Stock Option

    2024-02-27+317,000317,000 total
    Exercise: $0.46From: 2025-02-27Exp: 2034-02-27Common Stock (317,000 underlying)
Footnotes (2)
  • [F1]One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
  • [F2]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.

Issuer

Tonix Pharmaceuticals Holding Corp.

CIK 0001430306

Entity typeother

Related Parties

1
  • filerCIK 0001656531

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 5:06 PM ET
Size
8.0 KB